AW

Arun Walia

Active Director Director DIN 07191646
DIN 07191646 First appointment Jun 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Jun 2015
Shareholding value •••• Premium profile

About Arun Walia

Data last updated:

Arun Walia is a Director at Jonas Pharmaceuticals Private Limited (since 2017), Director at Aviotic Healthcare Private Limited (since 2018) and Director at Jonas Lifesciences Private Limited (since 2018). The companies operate in Trading, Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹1.74 Cr; the largest is Jonas Pharmaceuticals Private Limited at ₹86.8 Lakh (FY 2025). Earlier, Arun Walia was a Director at Torance Health Care Private Limited (2015–2018) and Director at Nevax Lifesciences Private Limited (2017) and 1 more.

DIN 07191646
Primary Designation Director
Industry Trading
First Appointment 30 Jun 2015
Oldest Company Age 12 yrs
Largest company Jonas Pharmaceuticals Private Limited · ₹86.8 Lakh (FY 2025)
Combined revenue ₹1.74 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 20172014₹86.8 Lakh (FY 2025)Active
Aviotic Healthcare Private Limited U24304HR2018PTC074099
Director16 May 20182018₹85.6 Lakh (FY 2025)Active
Jonas Lifesciences Private Limited U24100HR2018PTC074257
Director24 May 20182018₹1.1 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Torance Health Care Private Limited U24232HR2015PTC055916
Director30 Jun 20152015₹3.00 Cr (FY 2025)Active
Nevax Lifesciences Private Limited U24290HR2017PTC068169
Director16 Mar 20172017₹12.1 Lakh (FY 2023)Active
Director01 Dec 20172017₹57.2 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Arun Walia

NameDINCompanyDesignation
Avi Walia08923136Jonas Pharmaceuticals Private Limited , Aviotic Healthcare Private Limited and 1 moreDirector

Directorship timeline

Open interactive timeline →
Jonas Lifesciences Private Limited
Jonas Pharmaceuticals Private Limited
Aviotic Healthcare Private Limited
Torance Health Care Private Limited
Premium access

Shareholding and investment profile for Arun Walia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Walia

Arun Walia currently holds 3 directorships: Jonas Pharmaceuticals Private Limited (Director, since 20 Mar 2017, revenue ₹86.8 Lakh (FY 2025)); Aviotic Healthcare Private Limited (Director, since 16 May 2018, revenue ₹85.6 Lakh (FY 2025)); Jonas Lifesciences Private Limited (Director, since 24 May 2018, revenue ₹1.1 Lakh (FY 2025)).

Arun Walia was first appointed on 30 Jun 2015 as Director at Torance Health Care Private Limited. The most recent appointment on record is 24 May 2018 at Jonas Lifesciences Private Limited.

The 3 current companies of Arun Walia that report revenue have a combined latest revenue of ₹1.74 Cr: Jonas Pharmaceuticals Private Limited ₹86.8 Lakh (FY 2025); Aviotic Healthcare Private Limited ₹85.6 Lakh (FY 2025); Jonas Lifesciences Private Limited ₹1.1 Lakh (FY 2025).

Arun Walia held 3 earlier board appointments: Torance Health Care Private Limited (Director, 30 Jun 2015 to 31 May 2018); Nevax Lifesciences Private Limited (Director, 16 Mar 2017 to 14 Nov 2017); Novostar Pharmaceuticals Private Limited (Director, 01 Dec 2017 to 18 May 2018).

The current boards of Arun Walia's companies include Avi Walia (Jonas Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available